Literature DB >> 1919361

Intracellular survival of virulent Bordetella pertussis in human polymorphonuclear leukocytes.

L L Steed1, M Setareh, R L Friedman.   

Abstract

Little is known regarding the interaction of Bordetella pertussis with polymorphonuclear leukocytes (PMNL) or the role PMNL play as an initial line of defense against B. pertussis infection. An in vitro system was developed to establish conditions for the study of phagocytosis and killing of virulent B. pertussis by human PMNL. Phagocytosis of B. pertussis strains BP504, BP165, and BP338 occurred by opsonization with anti-B. pertussis antibody, while autologous normal human sera did not induce significant phagocytosis. In PMNL bacterial killing assays virulent B. pertussis strains survived PMNL bactericidal activities while Escherichia coli controls were readily killed. Electron microscopy studies using acid phosphatase as a lysosomal marker strongly suggested that B. pertussis inhibits phagosome-lysosome fusion in PMNL. These results indicate that virulent B. pertussis strains are capable of surviving intracellularly within PMNL and that such survival may be due to inhibition of phagosome-lysosome fusion.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1919361     DOI: 10.1002/jlb.50.4.321

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  25 in total

1.  Bordetella pertussis virulence factors affect phagocytosis by human neutrophils.

Authors:  C L Weingart; A A Weiss
Journal:  Infect Immun       Date:  2000-03       Impact factor: 3.441

2.  Phagocytosed Bordetella pertussis fails to survive in human neutrophils.

Authors:  D H Lenz; C L Weingart; A A Weiss
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

3.  Uptake and intracellular survival of Bordetella pertussis in human macrophages.

Authors:  R L Friedman; K Nordensson; L Wilson; E T Akporiaye; D E Yocum
Journal:  Infect Immun       Date:  1992-11       Impact factor: 3.441

4.  Bordetella pertussis induces respiratory burst activity in human polymorphonuclear leukocytes.

Authors:  L L Steed; E T Akporiaye; R L Friedman
Journal:  Infect Immun       Date:  1992-05       Impact factor: 3.441

5.  Modulation of adenylate cyclase toxin production as Bordetella pertussis enters human macrophages.

Authors:  H R Masure
Journal:  Proc Natl Acad Sci U S A       Date:  1992-07-15       Impact factor: 11.205

6.  Opsonophagocytic activity and other serological indications of Bordetella pertussis infection in military recruits in Norway.

Authors:  Audun Aase; Tove Karin Herstad; Samuel Merino; Kari Torkildsen Brandsdal; Bjørn Peter Berdal; Erja M Aleksandersen; Ingeborg S Aaberge
Journal:  Clin Vaccine Immunol       Date:  2007-05-16

7.  Phase variation affects long-term survival of Bordetella bronchiseptica in professional phagocytes.

Authors:  A Banemann; R Gross
Journal:  Infect Immun       Date:  1997-08       Impact factor: 3.441

8.  Invasion and intracellular survival of Bordetella bronchiseptica in mouse dendritic cells.

Authors:  C A Guzman; M Rohde; M Bock; K N Timmis
Journal:  Infect Immun       Date:  1994-12       Impact factor: 3.441

9.  Virulence of Bordetella bronchiseptica: role of adenylate cyclase-hemolysin.

Authors:  P Gueirard; N Guiso
Journal:  Infect Immun       Date:  1993-10       Impact factor: 3.441

10.  Use of the polymerase chain reaction to detect Bordetella pertussis in patients with mild or atypical symptoms of infection.

Authors:  G Schläpfer; H P Senn; R Berger; M Just
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1993-06       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.